Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Of surveyed and interviewed U.S. physicians who showed significant six-month improvement in follow-up vs. baseline wellness checks, 47% attributed the gain to active personal changes. Not far behind were those who credited active work-related changes—40% of the field.
The new entity, Precure, will be owned by both groups. Its work in detecting early disease for timely intervention stems from a research project launched this summer. The Mayo Clinic said Precure will make the results of that initiative actionable.
Any negotiations are currently in the early stages, sources told Reuters. If a deal closes, Waystar could be taken off the stock market and restructure itself as a private business.
Add lanes to a highway and the traffic only gets more congested. Add doctors to a local health system and waiting times increase. What explains these parallel paradoxes?
The new contract was signed just ahead of the Oct. 20 deadline. The insurer and academic health system were in dispute over reimbursement rates. The exact terms of the new multi-year agreement are unknown.
The new "TrumpRx.com" will sell Pfizer drugs at a heavily discounted price, direct-to-consumers. However, details on the initiative are not entirely clear.
Universal Health Services was found by a jury to be liable for fraud in an alleged scheme to destabilize Saint Mary’s during the COVID-19 pandemic. The ruling includes punitive damages.
The settlement was reached with the U.S. Department of Justice as part of Chapter 11 proceedings. Exactech is currently under restructuring that will see its business bought out by multiple investment firms.
As the national physician shortage deepens, cardiology is feeling the strain. Recruiting cardiologists can be hard enough—bringing them to rural America is especially challenging due to the risk of isolation and other concerns.
Patient Square Capital will be taking the company private when the all-cash deal closes in the first quarter of 2026, pending approval from Premier’s shareholders.
In May, a jury found the CVS subsidiary liable for filing 3.3 million fraudulent insurance claims between 2010 and 2018. The $949 million judgment was imposed in July.
Both companies are working on ChatGPT-like platforms designed exclusively for medical professionals. OpenEvidence accuses Doximity of attempting to steal its proprietary code, while the latter fires back with a defamation claim.